國家衛生研究院 NHRI:Item 3990099045/11313
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 853919      Online Users : 1327
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/11313


    Title: GRK5 is associated with the regulation of methadone dosage in heroin dependence
    Authors: Wang, SC;Chung, RH;Kuo, HW;Liu, TH;Fang, CP;Liu, SC;Liu, CC;Tsou, HH;Chen, ACH;Liu, YL
    Contributors: Center for Neuropsychiatric Research;Institute of Population Health Sciences
    Abstract: Background: There is no countable biomarker for opioid dependence treatment responses thus far. In this study, we recruited Taiwanese methadone maintenance treatment (MMT) patients to search for genes involving the regulatory mechanisms of methadone dose by genome-wide association analyses. Methods: 344 Taiwanese MMT patients were included for a genome-wide association study. The involvement of GRK5 in opioid dependence was then further confirmed by gene expression study on lymphoblastoid cell lines derived from 3 independent age- and gender-matched groups, namely MMT patients, medication-free former heroin abusers, and normal controls. Results: The results indicated that GRK5, the gene encoding an enzyme related to mu-opioid receptor desensitization, is associated with methadone dose by additive model of gene-based association analysis (P=6.76x10-5). We found that 6 out of the 55 single nucleotide polymorphisms (SNPs) from the genome-wide genotype platform and 2 SNPs from the 29 additionally selected SNPs were significantly associated with methadone maintenance dose in both genotype and allele type (P</=0.006), especially in patients who were tested negative in the urine morphine test. The levels of GRK5 gene expression were similar between MMT patients and medication-free former heroin abusers. However, the normal controls showed a significantly lower level of GRK5 gene expression than the other groups (P=0.019). Conclusions: The results suggested an important role for GRK5 in the regulatory mechanisms of methadone dose and course of heroin dependence.
    Date: 2018-10
    Relation: International Journal of Neuropsychopharmacology. 2018 Oct;21(10):910-917.
    Link to: http://dx.doi.org/10.1093/ijnp/pyy066
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1461-1457&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000456101000003
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85054439077
    Appears in Collections:[Yu-Li Liu] Periodical Articles
    [Sheng-Chang Wang] Periodical Articles
    [Hsiao-Hui Sophie Tsou] Periodical Articles
    [Ren-Hua Chung] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    PUB30060048.pdf858KbAdobe PDF366View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback